Other News To Note
• Cubist Pharmaceuticals Inc., of Lexington, Mass., completed its acquisition of Adolor Corp. for approximately $221 million. All outstanding shares of Adolor were acquired for $4.25 per share in up-front cash plus one contingent payment right per share, entitling the holder to receive additional cash payments of up to $4.50 for each share owned if certain regulatory approvals and/or commercialization milestones for ADL5945 are achieved.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter